The New Paper

May 25, 2021

GenSight Biologics publishes study on partially recovered vision for blind man

GenSight Biologics announced the first peer-reviewed documentation of partial visual recovery for a blind patient with late-stage inherited retinal disease. The study used a technique called optogenetics, which uses flashes of light to control gene expression and neuron firing.
This story is from the May 25, 2021 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.